These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 31273192

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy.
    Quinlan KA, Reedich EJ, Arnold WD, Puritz AC, Cavarsan CF, Heckman CJ, DiDonato CJ.
    J Neurophysiol; 2019 Oct 01; 122(4):1297-1311. PubMed ID: 31365319
    [Abstract] [Full Text] [Related]

  • 23. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E, Mendoza-Ferreira N, Hosseinibarkooie S, Schneider S, Hupperich K, Tschanz T, Grysko V, Riessland M, Hammerschmidt M, Rigo F, Bennett CF, Kye MJ, Torres-Benito L, Wirth B.
    Brain; 2018 Aug 01; 141(8):2343-2361. PubMed ID: 29961886
    [Abstract] [Full Text] [Related]

  • 24. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S.
    Neurobiol Dis; 2013 Apr 01; 52():94-103. PubMed ID: 23268200
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction.
    Torri F, Mancuso M, Siciliano G, Ricci G.
    Int J Mol Sci; 2024 Jul 03; 25(13):. PubMed ID: 39000416
    [Abstract] [Full Text] [Related]

  • 27. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM, Blanco-Redondo B, Buettner JM, Pagiazitis JG, Fletcher EV, Sime Longang JK, Mentis GZ.
    J Neurosci; 2021 Jan 13; 41(2):376-389. PubMed ID: 33219005
    [Abstract] [Full Text] [Related]

  • 28. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
    Yoshida M, Kitaoka S, Egawa N, Yamane M, Ikeda R, Tsukita K, Amano N, Watanabe A, Morimoto M, Takahashi J, Hosoi H, Nakahata T, Inoue H, Saito MK.
    Stem Cell Reports; 2015 Apr 14; 4(4):561-8. PubMed ID: 25801509
    [Abstract] [Full Text] [Related]

  • 29. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC.
    J Chem Neuroanat; 2016 Oct 14; 76(Pt A):35-47. PubMed ID: 27038603
    [Abstract] [Full Text] [Related]

  • 30. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH, Nijssen J, Frost-Nylen J, Hedlund E.
    J Comp Neurol; 2016 May 01; 524(7):1424-42. PubMed ID: 26502195
    [Abstract] [Full Text] [Related]

  • 33. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K, Rossoll W, Kobsar I, Holtmann B, Jablonka S, Wessig C, Stoltenburg-Didinger G, Fischer U, Hübner C, Martini R, Sendtner M.
    Hum Mol Genet; 2004 Sep 15; 13(18):2031-42. PubMed ID: 15269181
    [Abstract] [Full Text] [Related]

  • 34. Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.
    Poort JE, Rheuben MB, Breedlove SM, Jordan CL.
    Hum Mol Genet; 2016 Sep 01; 25(17):3768-3783. PubMed ID: 27493028
    [Abstract] [Full Text] [Related]

  • 35. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
    Robbins KL, Glascock JJ, Osman EY, Miller MR, Lorson CL.
    Hum Mol Genet; 2014 Sep 01; 23(17):4559-68. PubMed ID: 24722206
    [Abstract] [Full Text] [Related]

  • 36. Pathologic Alterations in the Proteome of Synaptosomes from a Mouse Model of Spinal Muscular Atrophy.
    Eshraghi M, Gombar R, De Repentigny Y, Vacratsis PO, Kothary R.
    J Proteome Res; 2019 Aug 02; 18(8):3042-3051. PubMed ID: 31262178
    [Abstract] [Full Text] [Related]

  • 37. Nifedipine Ameliorates Cellular Differentiation Defects of Smn-Deficient Motor Neurons and Enhances Neuromuscular Transmission in SMA Mice.
    Tejero R, Alsakkal M, Hennlein L, Lopez-Cabello AM, Jablonka S, Tabares L.
    Int J Mol Sci; 2023 Apr 21; 24(8):. PubMed ID: 37108811
    [Abstract] [Full Text] [Related]

  • 38. Neurotransmitter release in motor nerve terminals of a mouse model of mild spinal muscular atrophy.
    Ruiz R, Tabares L.
    J Anat; 2014 Jan 21; 224(1):74-84. PubMed ID: 23489475
    [Abstract] [Full Text] [Related]

  • 39. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
    Hosseinibarkooie S, Peters M, Torres-Benito L, Rastetter RH, Hupperich K, Hoffmann A, Mendoza-Ferreira N, Kaczmarek A, Janzen E, Milbradt J, Lamkemeyer T, Rigo F, Bennett CF, Guschlbauer C, Büschges A, Hammerschmidt M, Riessland M, Kye MJ, Clemen CS, Wirth B.
    Am J Hum Genet; 2016 Sep 01; 99(3):647-665. PubMed ID: 27499521
    [Abstract] [Full Text] [Related]

  • 40. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC, Denton KR, Wang ZB, Zhang X, Li XJ.
    Dis Model Mech; 2016 Jan 01; 9(1):39-49. PubMed ID: 26586529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.